• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小 RNA 拉链锁定 miRNA 分子并阻断哺乳动物细胞中的 miRNA 功能。

Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells.

机构信息

Research Center for Translational Medicine, Key Laboratory of Arrhythmias of the Ministry of Education of China, East Hospital, Tongji University School of Medicine, 150 Jimo Road, Shanghai 200120, China.

East Hospital, Dalian Medical University, 150 Jimo Road, Shanghai 200120, China.

出版信息

Nat Commun. 2017 Jan 3;8:13964. doi: 10.1038/ncomms13964.

DOI:10.1038/ncomms13964
PMID:28045030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5216115/
Abstract

MicroRNAs (miRNAs) loss-of-function phenotypes are mainly induced by chemically modified antisense oligonucleotides. Here we develop an alternative inhibitor for miRNAs, termed 'small RNA zipper'. It is designed to connect miRNA molecules end to end, forming a DNA-RNA duplex through a complementary interaction with high affinity, high specificity and high stability. Two miRNAs, miR-221 and miR-17, are tested in human breast cancer cell lines, demonstrating the 70∼90% knockdown of miRNA levels by 30-50 nM small RNA zippers. The miR-221 zipper shows capability in rescuing the expression of target genes of miR-221 and reversing the oncogenic function of miR-221 in breast cancer cells. In addition, we demonstrate that the miR-221 zipper attenuates doxorubicin resistance with higher efficiency than anti-miR-221 in human breast cancer cells. Taken together, small RNA zippers are a miRNA inhibitor, which can be used to induce miRNA loss-of-function phenotypes and validate miRNA target genes.

摘要

微小 RNA(miRNA)功能丧失表型主要是由化学修饰的反义寡核苷酸诱导的。在这里,我们开发了一种 miRNA 的替代抑制剂,称为“小 RNA 拉链”。它被设计用来将 miRNA 分子连接起来,通过与高亲和力、高特异性和高稳定性的互补相互作用,形成 DNA-RNA 双链体。我们在人乳腺癌细胞系中测试了两种 miRNA,miR-221 和 miR-17,结果表明,30-50 nM 的小 RNA 拉链可以将 miRNA 水平降低 70∼90%。miR-221 拉链具有恢复 miR-221 靶基因表达并逆转 miR-221 在乳腺癌细胞中致癌功能的能力。此外,我们证明 miR-221 拉链在人乳腺癌细胞中比抗 miR-221 更有效地减弱阿霉素耐药性。总之,小 RNA 拉链是一种 miRNA 抑制剂,可用于诱导 miRNA 功能丧失表型和验证 miRNA 靶基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/607b04a967c6/ncomms13964-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/e749abd64aa0/ncomms13964-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/b5ae01830dbd/ncomms13964-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/91b440177d31/ncomms13964-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/6eec43ffcace/ncomms13964-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/ecb06ebd47e2/ncomms13964-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/607b04a967c6/ncomms13964-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/e749abd64aa0/ncomms13964-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/b5ae01830dbd/ncomms13964-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/91b440177d31/ncomms13964-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/6eec43ffcace/ncomms13964-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/ecb06ebd47e2/ncomms13964-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48b9/5216115/607b04a967c6/ncomms13964-f6.jpg

相似文献

1
Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells.小 RNA 拉链锁定 miRNA 分子并阻断哺乳动物细胞中的 miRNA 功能。
Nat Commun. 2017 Jan 3;8:13964. doi: 10.1038/ncomms13964.
2
Inhibition of miR-21 by 3'/5'-Serinyl-Capped 2'-O-Methyl RNA Interspersed with 2'-O-(2-Amino-3-Methoxypropyl) Uridine Units.3'/5'-丝氨酰封端的2'-O-甲基RNA与2'-O-(2-氨基-3-甲氧基丙基)尿苷单元相间排列对miR-21的抑制作用
Nucleic Acid Ther. 2016 Oct;26(5):327-334. doi: 10.1089/nat.2015.0591. Epub 2016 Jul 25.
3
MicroRNA-222 Promotes the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Targeting P27 and TIMP3.微小RNA-222通过靶向P27和TIMP3促进肺动脉平滑肌细胞增殖。
Cell Physiol Biochem. 2017;43(1):282-292. doi: 10.1159/000480371. Epub 2017 Aug 30.
4
Starvation stress attenuates the miRNA-target interaction in suppressing breast cancer cell proliferation.饥饿应激减弱了 miRNA 靶向相互作用,从而抑制乳腺癌细胞增殖。
BMC Cancer. 2020 Jul 6;20(1):627. doi: 10.1186/s12885-020-07118-3.
5
The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR).长链非编码RNA XIST通过靶向雄激素受体(AR)与miR-124相互作用,调节膀胱癌的生长、侵袭和迁移。
Cell Physiol Biochem. 2017;43(1):405-418. doi: 10.1159/000480419. Epub 2017 Aug 31.
6
Development of Novel antimiRzymes for Targeted Inhibition of miR-21 Expression in Solid Cancer Cells.新型 antimiRzymes 的开发用于实体癌细胞中 miR-21 表达的靶向抑制。
Molecules. 2019 Jul 7;24(13):2489. doi: 10.3390/molecules24132489.
7
miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27(kip1) expression.微小RNA-222通过抑制p27(kip1)的表达赋予乳腺癌细胞对阿霉素的抗性。
Gene. 2016 Sep 15;590(1):44-50. doi: 10.1016/j.gene.2016.06.013. Epub 2016 Jun 6.
8
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27 pathway.微小RNA-222通过PTEN/Akt/p27信号通路诱导乳腺癌对阿霉素产生耐药性。
Tumour Biol. 2016 Nov;37(11):15315-15324. doi: 10.1007/s13277-016-5341-2. Epub 2016 Oct 4.
9
MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.微小 RNA-574 通过下调乳腺癌细胞中的 SMAD4 增强多柔比星耐药性。
Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1342-1350. doi: 10.26355/eurrev_201803_14476.
10
miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.微小RNA-218靶向存活素并调节乳腺癌对化疗药物的耐药性。
Breast Cancer Res Treat. 2015 Jun;151(2):269-80. doi: 10.1007/s10549-015-3372-9. Epub 2015 Apr 22.

引用本文的文献

1
Perspectives in MicroRNA Therapeutics for Cystic Fibrosis.囊性纤维化的微小RNA治疗前景
Noncoding RNA. 2025 Jan 12;11(1):3. doi: 10.3390/ncrna11010003.
2
Engineered Exosomes Carrying miR-588 for Treatment of Triple Negative Breast Cancer Through Remodeling the Immunosuppressive Microenvironment.工程化外泌体携带 miR-588 通过重塑免疫抑制微环境治疗三阴性乳腺癌。
Int J Nanomedicine. 2024 Jan 23;19:743-758. doi: 10.2147/IJN.S440619. eCollection 2024.
3
The Role of microRNA in Spermatogenesis: Is There a Place for Fertility Preservation Innovation?

本文引用的文献

1
miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer.miR-221/222 通过控制基底样乳腺癌促进 S 期进入和细胞迁移。
Molecules. 2014 May 30;19(6):7122-37. doi: 10.3390/molecules19067122.
2
The principles of MiRNA-masking antisense oligonucleotides technology.微小RNA(miRNA)掩蔽反义寡核苷酸技术的原理
Methods Mol Biol. 2011;676:43-9. doi: 10.1007/978-1-60761-863-8_3.
3
Maintenance treatment in metastatic breast cancer.转移性乳腺癌的维持治疗。
微小 RNA 在精子发生中的作用:是否有创新的生育力保存空间?
Int J Mol Sci. 2023 Dec 29;25(1):460. doi: 10.3390/ijms25010460.
4
The miRNA-target interactions: An underestimated intricacy.miRNA 与靶基因的相互作用:被低估的复杂性。
Nucleic Acids Res. 2024 Feb 28;52(4):1544-1557. doi: 10.1093/nar/gkad1142.
5
Nanoparticles carrying paclitaxel and anti-miR-221 for breast cancer therapy triggered by ultrasound.携带紫杉醇和抗miR-221的纳米颗粒用于超声触发的乳腺癌治疗。
Cell Death Discov. 2023 Aug 15;9(1):298. doi: 10.1038/s41420-023-01594-9.
6
MicroRNAs in cancer metastasis: biological and therapeutic implications.微小 RNA 与癌症转移:生物学与治疗意义。
Expert Rev Mol Med. 2023 Mar 17;25:e14. doi: 10.1017/erm.2023.7.
7
Vaccine Formulation Strategies and Challenges Involved in RNA Delivery for Modulating Biomarkers of Cardiovascular Diseases: A Race from Laboratory to Market.用于调节心血管疾病生物标志物的RNA递送中的疫苗配方策略及挑战:从实验室到市场的竞赛
Vaccines (Basel). 2023 Jan 21;11(2):241. doi: 10.3390/vaccines11020241.
8
The Role of Non-Coding RNAs in Glioma.非编码RNA在胶质瘤中的作用
Biomedicines. 2022 Aug 20;10(8):2031. doi: 10.3390/biomedicines10082031.
9
MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention.微小 RNA 及其重大治疗影响:癌症干预的递药策略。
Cells. 2022 Jul 29;11(15):2332. doi: 10.3390/cells11152332.
10
Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner. bulge-forming miRNases 以序列特异性方式在中央环区切割致癌 miRNA。
Int J Mol Sci. 2022 Jun 12;23(12):6562. doi: 10.3390/ijms23126562.
Expert Rev Anticancer Ther. 2008 Dec;8(12):1907-12. doi: 10.1586/14737140.8.12.1907.
4
MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer.微小RNA-221/222负向调节雌激素受体α,并与乳腺癌的他莫昔芬耐药相关。
J Biol Chem. 2008 Nov 7;283(45):31079-86. doi: 10.1074/jbc.M806041200. Epub 2008 Sep 12.
5
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1.微小RNA-221/222通过靶向p27Kip1赋予乳腺癌对他莫昔芬的耐药性。
J Biol Chem. 2008 Oct 31;283(44):29897-903. doi: 10.1074/jbc.M804612200. Epub 2008 Aug 15.
6
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.细胞周期蛋白D1/微小RNA 17/20调控反馈环对乳腺癌细胞增殖的控制
J Cell Biol. 2008 Aug 11;182(3):509-17. doi: 10.1083/jcb.200801079.
7
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.微小RNA-200家族和微小RNA-205通过靶向锌指E盒结合蛋白1(ZEB1)和SIP1来调节上皮-间质转化。
Nat Cell Biol. 2008 May;10(5):593-601. doi: 10.1038/ncb1722. Epub 2008 Mar 30.
8
Endogenous human microRNAs that suppress breast cancer metastasis.抑制乳腺癌转移的内源性人类微小RNA
Nature. 2008 Jan 10;451(7175):147-52. doi: 10.1038/nature06487.
9
miRNAs and their potential for use against cancer and other diseases.微小RNA及其用于对抗癌症和其他疾病的潜力。
Future Oncol. 2007 Oct;3(5):521-37. doi: 10.2217/14796694.3.5.521.
10
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells.微小RNA海绵:哺乳动物细胞中小RNA的竞争性抑制剂
Nat Methods. 2007 Sep;4(9):721-6. doi: 10.1038/nmeth1079. Epub 2007 Aug 12.